Biotech and Pharma Time Is Near "Biogen to the moon"

Certainly the "to the moon" for an established company like Biogen may be out of place but it makes the idea of the interest that big investors are demonstrating towards pharme and biotech companies in recent times.

From what I see on Miracle Viewer, the indicator that analyzes the market in search of the capital of big players, many of the capital of big investors are heading in these early days of June 2021 in the biotech and pharmaceutical sector.

Probably the attentions during the period of covid directed to the more IT technological field are diminishing and the capitals that flow must find a collocation in the companies and the categories of companies that have been less considered.

It’s the case of Biogen where the Marketmiracle advisor is reporting a considerable interest from the big investors but it’s also the case of other illustrious companies like $CLVS, $OTRK which I put back as connected ideas

In this case the Marketmiracle advisor gives me a signal of a small price increase (about 10%) but we are talking about a well-placed and well-run-in biotech company, an increase that will probably be reviewed in the next few hours for further leaps forward .

But let’s proceed by order
the signal provided by Marketmiracle is to go LONG on Biogen at a price of 272.55 usd for a target of 297.2232 usd or a potential increase of 9.05%

From the fundamental point of view the company seems to be underestimated by about 43% ( estimate made by analysts of sites of my reference) so actually the signal could be a good opportunity to start a phase of accumulation or trade bites and escapes.

From the graphical point of view everything comes back and I would expect a movement similar to the one I drew on the graph.

This idea is based on the signal generated by the Marketmiracle advisor whose link you can find by scrolling at the bottom of this page.